Erratum: Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells (Cell Reports (2018) 25(4) (1018–1026.e4), (S2211124718315341) (10.1016/j.celrep.2018.09.074))

Mehmet G. Badur, Thangaselvam Muthusamy, Seth J. Parker, Shenghong Ma, Samuel K. McBrayer, Thekla Cordes, Jose H. Magana, Kun Liang Guan, Christian M. Metallo

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

(Cell Reports 25, 1018–1026.e1–e4; October 23, 2018) In the originally published version of this article, the word “Cells” in the title was mistakenly changed to “Sells” during the production process. The title has been corrected online and also appears here. The production team apologizes for the error.

Original languageEnglish (US)
Number of pages1
JournalCell Reports
Volume25
Issue number6
DOIs
StatePublished - Nov 6 2018
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Erratum: Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells (Cell Reports (2018) 25(4) (1018–1026.e4), (S2211124718315341) (10.1016/j.celrep.2018.09.074))'. Together they form a unique fingerprint.

  • Cite this